A

AM Diabetes & Endocrinology Center | Bartlett, TN

Research site

(Unclaimed)

Location

3025 Kate Bond Rd, Bartlett, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Teplizumab

DiaPep277

PROCHYMAL®

Metformin

Retatrutide

Canagliflozin

teplizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes (βETA PRESERVE)

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment.The purpose of this study is to meas...

Enrolling

Type 1 Diabetes Mellitus

Other: Placebo

Drug: Teplizumab

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and ren...

Enrolling

Type 2 Diabetes

Drug: Retatrutide

Drug: Placebo